A Double-blind, Randomized,Placebo-controlled, Multicenter Study Assessingthe Impact of Olpasiran on MajorCardiovascular Events in Patients withAtherosclerotic Cardiovascular Disease andElevated Lipoprotein (a)

Project: Research project

Project Details

Description

A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a)
StatusActive
Effective start/end date9/21/233/31/28

Funding

  • AMGEN INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.